The CEO said in the AGM speech that the first patient in the US trial would not be until late 2023. That says to me there might not be much to update this half. Unsure why they wouldn't start ASAP especially giving funding it cant be an issue after the cap raise. I do recall them saying it wasn't a straight forward ambulance trial so probably more work to be be done. Either way a launch in the US would therefore be at least 3 years away.
The lack of market updates is frustrating. If you had something good to report wouldn't you release it.
Enoonmai makes a good point re. the UK. They have been there for years and it seems to have grown, but not exponentially. There old CEO had said years back the paediatric trial was key to getting more ambulance services to adopt the whistle. Don't ever recall hearing an update re. that trial?
The CEO said in the AGM speech that the first patient in the US...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.035(7.95%) |
Mkt cap ! $34.95M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 45.0¢ | 40.5¢ | $82.07K | 192.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6002 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 3044 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
40.5¢ |
Change
-0.035 ( 3.69 %) |
||||
| Open | High | Low | Volume | ||
| 42.5¢ | 43.5¢ | 40.5¢ | 43358 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| MVP (ASX) Chart |